Lundbeck
HLUN-B.CO
#2699
Rank
S$8.18 B
Marketcap
S$8.63
Share price
0.94%
Change (1 day)
7.04%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): S$1.11 Billion

According to Lundbeck's latest financial reports the company's current earnings are S$3.61 Billion. In 2024 the company made an earning of S$0.70 Billion, an increase over its 2023 earnings that were of S$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$1.11 B58.68%
2024 S$0.70 B25.74%
2023 S$0.55 B21.77%
2022 S$0.45 B31.57%
2021 S$0.34 B-4.61%
2020 S$0.36 B-45.06%
2019 S$0.66 B-34.04%
2018 S$1.01 B12.83%
2017 S$0.89 B93.99%
2016 S$0.46 B-137.28%
2015 -S$1.24 Billion-1246.24%
2014 S$0.10 B-72.36%
2013 S$0.39 B4.38%
2012 S$0.37 B-55.18%
2011 S$0.83 B5.65%
2010 S$0.79 B-5.9%
2009 S$0.84 B